Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).
Kim J, Lim W, Kim EK, Kim MK, Paik NS, Jeong SS, Yoon JH, Park CH, Ahn SH, Kim LS, Han S, Nam SJ, Kang HS, Kim SI, Yoo YB, Jeong J, Kim TH, Kang T, Kim SW, Jung Y, Lee JE, Kim KS, Yu JH, Chae BJ, Jung SY, Kang E, Choi SY, Moon HG, Noh DY, Han W.
Kim J, et al. Among authors: kim th, kim sw, kim ek, kim si, kim ls, kim ks, kim mk.
BMC Cancer. 2014 Mar 10;14:170. doi: 10.1186/1471-2407-14-170.
BMC Cancer. 2014.
PMID: 24612502
Free PMC article.
Clinical Trial.